ArticleMediterranean journal of rheumatology2025

HCV Reactivation Risk in Patients Undergoing Treatment for Inflammatory Arthritis and Connective Tissue Diseases.

Maria Pappa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.